|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 141.00 GBX | -0.70% |
|
-3.42% | +10.16% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 561K | 724K | -1.75M | -1.7M | 97K | |||||
Depreciation & Amortization - CF | 134K | 304K | 314K | 321K | 457K | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 882K | 1.35M | 2.96M | 2.84M | 3.88M | |||||
Depreciation & Amortization, Total | 1.02M | 1.66M | 3.27M | 3.16M | 4.33M | |||||
Amortization of Deferred Charges, Total - (CF) | 783K | 1.35M | 1.5M | 1.47M | 1.48M | |||||
(Gain) Loss From Sale Of Asset | - | - | 3K | - | - | |||||
Asset Writedown & Restructuring Costs | - | - | - | 87K | - | |||||
Stock-Based Compensation (CF) | 373K | 536K | 445K | 1.02M | 915K | |||||
Other Operating Activities, Total | -505K | 1.16M | -624K | -2.08M | -1.14M | |||||
Change In Accounts Receivable | -1.5M | -1.59M | -2.16M | -4.68M | -5.15M | |||||
Change In Accounts Payable | -159K | 1.27M | 618K | 3.37M | 643K | |||||
Cash from Operations | 570K | 5.1M | 1.31M | 651K | 1.18M | |||||
Capital Expenditure | -565K | -186K | -125K | -100K | -71K | |||||
Sale (Purchase) of Intangible assets | -5.04M | -4.68M | -4.73M | -4.53M | -6.38M | |||||
Other Investing Activities, Total | - | 111K | 646K | 601K | 317K | |||||
Cash from Investing | -5.6M | -4.76M | -4.21M | -4.03M | -6.13M | |||||
Long-Term Debt Issued, Total | - | - | - | - | - | |||||
Total Debt Issued | - | - | - | - | - | |||||
Long-Term Debt Repaid, Total | -49K | -163K | -179K | -199K | -333K | |||||
Total Debt Repaid | -49K | -163K | -179K | -199K | -333K | |||||
Issuance of Common Stock | - | 129K | - | 136K | - | |||||
Repurchase of Common Stock | -165K | -98K | -49K | - | - | |||||
Common Dividends Paid | - | - | - | - | - | |||||
Common & Preferred Stock Dividends Paid | - | - | - | - | - | |||||
Other Financing Activities, Total | -56K | -59K | -11K | -1K | - | |||||
Cash from Financing | -270K | -191K | -239K | -64K | -333K | |||||
Foreign Exchange Rate Adjustments | -279K | 20K | -37K | -479K | -115K | |||||
Net Change in Cash | -5.58M | 166K | -3.17M | -3.92M | -5.4M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 56K | 59K | 11K | 1K | - | |||||
Cash Income Tax Paid (Refund) | 325K | -1.39M | -690K | 1.33M | 1.02M | |||||
Levered Free Cash Flow | -5.55M | -355K | -1.18M | -2.35M | -4.08M | |||||
Unlevered Free Cash Flow | -5.49M | -280K | -1.14M | -2.31M | -4.05M | |||||
Change In Net Working Capital | 2.46M | -602K | -291K | 2.04M | 4.56M | |||||
Net Debt Issued / Repaid | -49K | -163K | -179K | -199K | -333K |
Select your edition
All financial news and data tailored to specific country editions
















